Resultado de búsqueda
Hace 2 días · Phase 2/3 Trial of New Omicron-Targeted Vaccine Shows Efficacy in Adolescents. A single dose of the mRNA-1273.222 vaccine demonstrated strong immune responses against various omicron subvariants and showed a favorable safety profile compared to existing vaccines. Most people have some immunity to SARS-CoV-2, whether from vaccination, previous ...
Hace 14 horas · Isolation of a broad and potent neutralizing human monoclonal antibody which targets a conserved N-terminal epitope and neutralizes Omicron sub-lineages, including BA.2.86 and JN.1, offers ...
Hace 2 días · A subset of subjects who were seronegative for N-protein displayed similar differences in immune responses between ARCT-154 and Comirnaty against the Delta, Omicron BA.2, BA.2.86, and XBB.1.5.6 ...
Hace 2 días · Purpose The emergence of the SARS-CoV-2 Omicron variant has posed a significant global public health challenge. Elucidating the laboratory profiles of individuals infected with this variant is crucial for assessing organ damage. This study aimed to investigate the variations in liver function tests and their correlation with demographic characteristics and inflammatory markers in patients with ...
Hace 4 días · O imunizante desenvolvido pela BioNTech e Pfizer, atualmente utilizado na Alemanha, teve eficácia comprovada em um novo estudo.
Hace 2 días · ECDC utilises three categories of variant classification to communicate increasing levels of concern about a new or emerging SARS-CoV-2 variant: variant under monitoring (VUM), variant of interest (VOI) and variant of concern (VOC). Classification criteria and recommended Member state actions are available here:
Hace 5 días · The clinical effectiveness of early therapies for mild-to-moderate COVID-19, comparing antivirals and monoclonal antibodies (mAbs) during the Omicron era, has not been conclusively assessed through a post-approval comparative trial. We present a pooled analysis of two randomized clinical trials conducted during Omicron waves. Methods The MANTICO2/MONET trial is a pooled analysis of two ...
Anuncio
relacionado con: OmicronExpertise On Every Level To Craft Science & Technology Solutions In Life Science. Solving Problems In Life Science By Collaborating With the Global Scientific Community.
